Journal
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Volume 20, Issue 2, Pages 257-264Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/112067211002000201
Keywords
Epidemiology; Ocular allergy; Quality of life; Treatment
Categories
Funding
- Novartis Portugal
Ask authors/readers for more resources
PURPOSE. Ocular allergy is one of the most common ocular problems in clinical practice and, although easily identified and frequently a mild to moderate condition, it has relevant direct and indirect costs. To characterize clinical and demographic aspects of allergic conjunctivitis in Portugal, using a structured questionnaire. As a secondary outcome, patient's initial therapeutic and health care options, self-perception of health, and work/school absenteeism were also evaluated. METHODS. A cross-sectional study, in 16 ophthalmology departments of central or regional hospitals, in patients diagnosed with allergic conjunctivitis during the spring of 2006. RESULTS. A total of 220 patients were enrolled (mean age of 31.4 +/- 18.5 years). A quarter of these patients had >5 episodes of ocular allergy in the past year, 59.3% all year-round episodes, and most presented associated comorbidities (allergic rhinitis 45.9%, asthma 15.5%). They had significant impairment of their overall quality of life during an acute episode (45.6% >= 6 in a 10-point severity scale). Only 19.4% had an appointment with an ophthalmologist as a first action and most (56.1%) started with self treatment measures. Only 37.2% had a previous allergy diagnostic evaluation. CONCLUSIONS. In this cross-sectional study of allergic conjunctivitis patients seen in ophthalmology departments, we found a significant impairment of self-rated health status during an ocular allergy episode. Moreover, most patients had year-round episodes and started ocular allergy management with self treatment measures. (Eur J Ophthalmol 2010; 20: 257-64)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available